Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Ataga KI; Smith WR; De Castro LM; Swerdlow P; Saunthararajah Y; Castro O; Vichinsky E; Kutlar A; Orringer EP; Rigdon GC

doi:10.1182/blood-2007-08-110098

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Identifier:nobleid.org/w1/20260526/03436D82

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/03436D82.svg?ark=w1%2F20260526%2F03436D82)](https://nobleid.org/work/w1/20260526/03436D82)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Identifier:nobleid.org/w1/20260526/03436D82

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/03436D82.svg?ark=w1%2F20260526%2F03436D82)](https://nobleid.org/work/w1/20260526/03436D82)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work